Cryosurgery's Clinical Benefit: Delays Needed for Hormone Therapy for Most Men with Locally Recurrent Prostate Cancer

A recent Fox Chase Cancer Center study showed that 80 percent of men who have cryoablation surgery for recurrent prostate cancer can safely delay the start of androgen deprivation therapy (ADT) for two or more years and, as a result, avoid the risk of cardi...

Read More about Cryosurgery's Clinical Benefit: Delays Needed for Hormone Therapy for Most Men with Locally Recurrent Prostate Cancer